Literature DB >> 10391943

Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5.

T Tanoue1, T Moriguchi, E Nishida.   

Abstract

A group of dual specificity protein phosphatases negatively regulates members of the mitogen-activated protein kinase (MAPK) superfamily, which consists of three major subfamilies, MAPK/extracellular signal-regulated kinase (ERK), stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase (JNK), and p38. Nine members of this group of dual specificity phosphatases have previously been cloned. They show distinct substrate specificities for MAPKs, different tissue distribution and subcellular localization, and different modes of inducibility of their expression by extracellular stimuli. Here we have cloned and characterized a novel dual specificity phosphatase, which we have designated MKP-5. MKP-5 is a protein of 482 amino acids with a calculated molecular mass of 52.6 kDa and consists of 150 N-terminal amino acids of unknown function, two Cdc25 homology 2 regions in the middle, and a C-terminal catalytic domain. MKP-5 binds to p38 and SAPK/JNK, but not to MAPK/ERK, and inactivates p38 and SAPK/JNK, but not MAPK/ERK. p38 is a preferred substrate. The subcellular localization of MKP-5 is unique; it is present evenly in both the cytoplasm and the nucleus. MKP-5 mRNA is widely expressed in various tissues and organs, and its expression in cultured cells is elevated by stress stimuli. These results suggest that MKP-5 is a novel type of dual specificity phosphatase specific for p38 and SAPK/JNK.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391943     DOI: 10.1074/jbc.274.28.19949

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

1.  Fluid shear stress inhibits TNF-alpha activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: Inhibitory crosstalk among MAPK family members.

Authors:  J Surapisitchat; R J Hoefen; X Pi; M Yoshizumi; C Yan; B C Berk
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

2.  The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase.

Authors:  Anindita Kar-Roy; Hasan Korkaya; Ruchi Oberoi; Sunil Kumar Lal; Shahid Jameel
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

3.  Map kinase phosphatase 5 protects against sepsis-induced acute lung injury.

Authors:  Feng Qian; Jing Deng; Benjamin N Gantner; Richard A Flavell; Chen Dong; John W Christman; Richard D Ye
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-03       Impact factor: 5.464

4.  Dual-specificity phosphatase 10 is fused to MDS1/EVI1-like gene 1 in a case of acute myelogenous leukemia with der1t1;1(p36.3;q21).

Authors:  Mitsuho Noguchi; Haruko Tashiro; Ryosuke Shirasaki; Moritaka Gotoh; Kazuo Kawasugi; Naoki Shirafuji
Journal:  Int J Hematol       Date:  2007-02       Impact factor: 2.490

5.  Beneficial innate signaling interference for antibacterial responses by a Toll-like receptor-mediated enhancement of the MKP-IRF3 axis.

Authors:  Hideo Negishi; Kosuke Matsuki; Nobuyasu Endo; Hana Sarashina; Shoji Miki; Atsushi Matsuda; Keiko Fukazawa; Naoko Taguchi-Atarashi; Hiroaki Ikushima; Hideyuki Yanai; Junko Nishio; Kenya Honda; Yoichiro Fujioka; Yusuke Ohba; Tetsuo Noda; Shun'ichiro Taniguchi; Eisuke Nishida; Yongliang Zhang; Hongbo Chi; Richard A Flavell; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

Review 6.  Regulation of cardiac hypertrophy and remodeling through the dual-specificity MAPK phosphatases (DUSPs).

Authors:  Ruijie Liu; Jeffery D Molkentin
Journal:  J Mol Cell Cardiol       Date:  2016-08-27       Impact factor: 5.000

7.  Enzymatic activity and substrate specificity of mitogen-activated protein kinase p38alpha in different phosphorylation states.

Authors:  Yuan-Yuan Zhang; Zi-Qing Mei; Jia-Wei Wu; Zhi-Xin Wang
Journal:  J Biol Chem       Date:  2008-07-31       Impact factor: 5.157

8.  Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity.

Authors:  Hui-Ming Chen; William van der Touw; Yuan Shuo Wang; Kyeongah Kang; Sunny Mai; Jilu Zhang; Dayanira Alsina-Beauchamp; James A Duty; Sathish Kumar Mungamuri; Bin Zhang; Thomas Moran; Richard Flavell; Stuart Aaronson; Hong-Ming Hu; Hisashi Arase; Suresh Ramanathan; Raja Flores; Ping-Ying Pan; Shu-Hsia Chen
Journal:  J Clin Invest       Date:  2018-10-22       Impact factor: 14.808

Review 9.  Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms.

Authors:  Mohammad Athar; Jung Ho Back; Levy Kopelovich; David R Bickers; Arianna L Kim
Journal:  Arch Biochem Biophys       Date:  2009-06-15       Impact factor: 4.013

10.  Trisomy 12 CLLs progress through NOTCH1 mutations.

Authors:  V Balatti; S Lerner; L Rizzotto; L Z Rassenti; A Bottoni; A Palamarchuk; L Cascione; H Alder; M J Keating; T J Kipps; Y Pekarsky; C M Croce
Journal:  Leukemia       Date:  2012-08-20       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.